Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 1,746 | 2,159 | 2,249 | 1,090 | 3,816 |
| Operating Income | -1,746 | -2,159 | -2,249 | -1,090 | -3,816 |
| Interest Expense | 0 | 0 | 0 | 186 | 878 |
| Other Income | 30 | 25 | -433 | 7 | -3,497 |
| Pre-tax Income | -1,716 | -2,134 | -2,683 | -1,269 | -8,191 |
| Net Income Continuous | -1,716 | -2,134 | -2,683 | -1,269 | -8,191 |
| Net Income | $-1,716 | $-2,134 | $-2,683 | $-1,269 | $-8,191 |
| EPS Basic Total Ops | -106.25 | -131.25 | -206.25 | -212.50 | -925.00 |
| EPS Basic Continuous Ops | -104.61 | -130.48 | -203.21 | -217.13 | -922.90 |
| EPS Diluted Total Ops | -106.25 | -131.25 | -206.25 | -212.50 | -925.00 |
| EPS Diluted Continuous Ops | -104.61 | -130.48 | -203.21 | -217.13 | -922.90 |
| EBITDA(a) | $-1,746 | $-2,159 | $-2,249 | $-904 | $-3,711 |